PDS Biotechnology Valuation
| PDSB Stock | USD 1.66 0.14 9.21% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. PDS Biotechnology Corp holds a recent Real Value of $4.1 per share. The prevailing price of the company is $1.66. Our model determines the value of PDS Biotechnology Corp from inspecting the company fundamentals such as Return On Asset of -0.4, return on equity of -1.28, and Shares Outstanding of 37.41 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting PDS Biotechnology's valuation include:
Undervalued
Today
Please note that PDS Biotechnology's price fluctuation is risky at this time. Calculation of the real value of PDS Biotechnology Corp is based on 3 months time horizon. Increasing PDS Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since PDS Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PDS Stock. However, PDS Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.66 | Real 4.1 | Target 11.5 | Hype 1.81 | Naive 1.8 |
The real value of PDS Stock, also known as its intrinsic value, is the underlying worth of PDS Biotechnology Corp Company, which is reflected in its stock price. It is based on PDS Biotechnology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PDS Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PDS Biotechnology Corp helps investors to forecast how PDS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PDS Biotechnology more accurately as focusing exclusively on PDS Biotechnology's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use PDS Biotechnology's intrinsic value based on its ongoing forecasts of PDS Biotechnology's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against PDS Biotechnology's closest peers. If more than one evaluation category is relevant for PDS Biotechnology we suggest using both methods to arrive at a better estimate.
PDS Biotechnology Cash |
|
PDS Valuation Trend
Comparing PDS Biotechnology's enterprise value against its market capitalization is a good way to estimate the value of PDS Biotechnology Corp uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
PDS Biotechnology Total Value Analysis
PDS Biotechnology Corp is at this time projected to have valuation of 31.78 M with market capitalization of 62.1 M, debt of 23.85 M, and cash on hands of 52.98 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PDS Biotechnology fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
31.78 M | 62.1 M | 23.85 M | 52.98 M |
PDS Biotechnology Asset Utilization
One of the ways to look at asset utilization of PDS is to check how much profit was generated for every dollar of assets it reports. PDS Biotechnology holds a negative application of assets of -0.4 pct., losing $0.003995 for each dollar of assets held by the company. Unsuccessful asset utilization implies the company is being less competent with each dollar of assets it holds. Put it differently, asset utilization of PDS Biotechnology Corp shows how unproductive it operates for each dollar spent on its assets.PDS Biotechnology Ownership Allocation
PDS Biotechnology owns a total of 37.41 Million outstanding shares. PDS Biotechnology holds 3.99 pct. of its outstanding shares held by insiders and 12.35 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PDS Biotechnology Profitability Analysis
Net Loss for the year was (42.94 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PDS Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PDS Biotechnology and how it compares across the competition.
About PDS Biotechnology Valuation
The stock valuation mechanism determines PDS Biotechnology's current worth on a weekly basis. Our valuation model uses a comparative analysis of PDS Biotechnology. We calculate exposure to PDS Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PDS Biotechnology's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -51.6 K | -54.2 K |
PDS Biotechnology Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 31 M |
PDS Biotechnology Current Valuation Indicators
Valuation refers to the process of determining the present value of PDS Biotechnology Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value PDS we look at many different elements of the entity such as PDS's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as PDS Biotechnology, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use PDS Biotechnology's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes PDS Biotechnology's worth.Complementary Tools for PDS Stock analysis
When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |